Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1989 Oct;42(10):1088–1091. doi: 10.1136/jcp.42.10.1088

Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes.

R J Sokol 1, S Hewitt 1, D J Booker 1
PMCID: PMC501869  PMID: 2584409

Abstract

Immunohaematological investigations were carried out in 46 patients with erythrocyte autoantibodies associated with myelodysplastic syndromes. Eight patients had refractory anaemia, 17 refractory anaemia with ring sideroblasts, 11 refractory anaemia with excess of blasts, four chronic myelomonocytic leukaemia, five refractory anaemia with excess of blasts in transformation and one could not be classified. Standard agglutination direct antiglobulin tests showed that the red cells were most often coated with IgG and C3d, though increased amounts of IgM or IgA were also found in 15 of 35 cases (43%) when the more sensitive enzyme linked method was used. The IgG antibodies were predominantly of IgG1 subclass. Clinically important autoimmune haemolysis occurred in 15 patients, and was of "warm", "cold," and "mixed" types in seven, four, and four cases, respectively: it is important to recognise its presence in view of the good response to treatment. The increased incidence of erythrocyte autoantibodies in myelodysplastic syndromes is thought to be one manifestation of disturbed immune homeostasis.

Full text

PDF
1091

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. M. Classification of the myelodysplastic syndromes. Clin Haematol. 1986 Nov;15(4):909–923. [PubMed] [Google Scholar]
  2. Bynoe A. G., Scott C. S., Ford P., Roberts B. E. Decreased T helper cells in the myelodysplastic syndromes. Br J Haematol. 1983 May;54(1):97–102. doi: 10.1111/j.1365-2141.1983.tb02071.x. [DOI] [PubMed] [Google Scholar]
  3. Cazzola M., Barosi G., Berzuini C., Dacco M., Orlandi E., Stefanelli M., Ascari E. Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol. 1982 Jan;50(1):55–62. doi: 10.1111/j.1365-2141.1982.tb01890.x. [DOI] [PubMed] [Google Scholar]
  4. Colombat P. H., Renoux M., Lamagnere J. P., Renoux G. Immunologic indices in myelodysplastic syndromes. Cancer. 1988 Mar 15;61(6):1075–1081. doi: 10.1002/1097-0142(19880315)61:6<1075::aid-cncr2820610604>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  5. Colombat P., Renoux M., Lamagnere J. P., Renoux G. T cell function in refractory anaemia with excess blasts. Br J Haematol. 1984 Jan;56(1):171–173. doi: 10.1111/j.1365-2141.1984.tb01284.x. [DOI] [PubMed] [Google Scholar]
  6. Economopoulos T., Economidou J., Giannopoulos G., Terzoglou C., Papageorgiou E., Dervenoulas J., Arseni P., Hadjioannou J., Raptis S. Immune abnormalities in myelodysplastic syndromes. J Clin Pathol. 1985 Aug;38(8):908–911. doi: 10.1136/jcp.38.8.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Greenberg P. L. Biologic nature of the myelodysplastic syndromes. Acta Haematol. 1987;78 (Suppl 1):94–99. doi: 10.1159/000205911. [DOI] [PubMed] [Google Scholar]
  8. Harkness R. A., Lund R. J. Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia. J Clin Pathol. 1983 Jan;36(1):1–8. doi: 10.1136/jcp.36.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jacobs A., Clark R. E. Pathogenesis and clinical variations in the myelodysplastic syndromes. Clin Haematol. 1986 Nov;15(4):925–951. [PubMed] [Google Scholar]
  10. Laine M. L., Beattie K. M. Frequency of alloantibodies accompanying autoantibodies. Transfusion. 1985 Nov-Dec;25(6):545–546. doi: 10.1046/j.1537-2995.1985.25686071427.x. [DOI] [PubMed] [Google Scholar]
  11. Longster G. H., Johnson E. IgM anti-D as auto-antibody in a case of 'cold' auto-immune haemolytic anaemia. Vox Sang. 1988;54(3):174–176. doi: 10.1111/j.1423-0410.1988.tb03895.x. [DOI] [PubMed] [Google Scholar]
  12. Mufti G. J., Figes A., Hamblin T. J., Oscier D. G., Copplestone J. A. Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. Br J Haematol. 1986 May;63(1):143–147. doi: 10.1111/j.1365-2141.1986.tb07504.x. [DOI] [PubMed] [Google Scholar]
  13. Mufti G. J., Stevens J. R., Oscier D. G., Hamblin T. J., Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol. 1985 Mar;59(3):425–433. doi: 10.1111/j.1365-2141.1985.tb07329.x. [DOI] [PubMed] [Google Scholar]
  14. Sacher R. A., McGinniss M. M., Shashaty G. G., Jacobson R. J., Rath C. E. The occurrence of an auto-immune hemolytic anemia with anti-U specificity in a patient with myelodysplastic syndrome. Am J Clin Pathol. 1982 Mar;77(3):356–359. doi: 10.1093/ajcp/77.3.356. [DOI] [PubMed] [Google Scholar]
  15. Seitanides B., Antonopoulou A., Karabelis A. Immunological abnormalities in myelodysplastic syndrome. J Clin Pathol. 1988 Aug;41(8):922–923. doi: 10.1136/jcp.41.8.922-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sokol R. J., Hewitt S. Autoimmune hemolysis: a critical review. Crit Rev Oncol Hematol. 1985;4(2):125–154. doi: 10.1016/s1040-8428(85)80013-5. [DOI] [PubMed] [Google Scholar]
  17. Sokol R. J., Hewitt S., Booker D. J., Stamps R., Booth J. R. An enzyme-linked direct antiglobulin test for assessing erythrocyte bound immunoglobulins. J Immunol Methods. 1988 Jan 21;106(1):31–35. doi: 10.1016/0022-1759(88)90268-2. [DOI] [PubMed] [Google Scholar]
  18. Sokol R. J., Hewitt S., Stamps B. K. Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre. Br Med J (Clin Res Ed) 1981 Jun 20;282(6281):2023–2027. doi: 10.1136/bmj.282.6281.2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sokol R. J., Hewitt S., Stamps B. K. Autoimmune hemolysis: mixed warm and cold antibody type. Acta Haematol. 1983;69(4):266–274. doi: 10.1159/000206903. [DOI] [PubMed] [Google Scholar]
  20. Sokol R. J., Hewitt S., Stamps B. K. Erythrocyte autoantibodies, autoimmune haemolysis and pregnancy. Vox Sang. 1982;43(4):169–176. doi: 10.1111/j.1423-0410.1982.tb00008.x. [DOI] [PubMed] [Google Scholar]
  21. Solal-Celigny P., Desaint B., Herrera A., Chastang C., Amar M., Vroclans M., Brousse N., Mancilla F., Renoux M., Bernard J. F. Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases. Blood. 1984 Mar;63(3):634–638. [PubMed] [Google Scholar]
  22. Wallhermfechtel M. A., Pohl B. A., Chaplin H. Alloimmunization in patients with warm autoantibodies. A retrospective study employing three donor alloabsorptions to aid in antibody detection. Transfusion. 1984 Nov-Dec;24(6):482–485. doi: 10.1046/j.1537-2995.1984.24685066805.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES